2025, Número 4
Siguiente >>
Cir Card Mex 2025; 10 (4)
Supervivencia frente a alivio de síntomas: el dilema quirúrgico en la insuficiencia mitral funcional isquémica
García-Villarreal OA
Idioma: Ingles.
Referencias bibliográficas: 8
Paginas: 103-104
Archivo PDF: 536.12 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Erratum in: Circulation. 2022;145(11):e771. doi: 10.1161/CIR.0000000000001061.
Velazquez EJ, Lee KL, Jones RH, et al; STICHES Investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511-1520. doi: 10.1056/NEJMoa1602001.
García-Villarreal OA. Is there still a role for isolated mitral valve surgery in functional mitral regurgitation? A contemporary review. Gac Med Mex. 2025;161(3):257-265. doi: 10.24875/GMM.25000018.
Naser N. Clinical implications of functional mitral regurgitation severity in patients with heart failure with reduced ejection fraction (HFrEF). Med Arch. 2022;76(1):17-22. doi: 10.5455/medarh.2022.76.17-22.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.
Vahanian A, Beyersdorf F, Praz F, et al.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395. Erratum in: Eur Heart J. 2022;43(21):2022. doi: 10.1093/eurheartj/ehac051.
Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49(22):2191-2201. doi: 10.1016/j.jacc.2007.02.043.
Michler RE, Smith PK, Parides DL, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932-1941. doi: 10.1056/NEJMoa1602003.